TCMBANKIN040256 |
norcepharadione B |
CHEMBL227414; AKOS028108617; Norcepharadione B; 15,16-DIMETHOXY-10-AZATETRACYCLO[7.7.1.0(2),?.0(1)(3),(1)?]HEPTADECA-1(17),2(7),3,5,8,13,15-HEPTAENE-11,12-DIONE; ZINC6017923; AC1Q6OMU; W1102; 1,2-dimethoxy-4h-dibenzo[de,g]quinoline-4,5(6h)-dione; 15,16-DIMETHOXY-10-AZATETRACYCLO[7.7.1.0(2),?.0(1)(3),(1)?]HEPTADECA-1(16),2,4,6,8,13(17),14-HEPTAENE-11,12-DIONE; 57576-41-7; 4CN-2031; CTK5A7091; AC1L4O6W; 4H-Dibenzo[de,g]quinoline-4,5(6H)-dione, 1,2-dimethoxy-; norcepharadione; BG01598744; MolPort-035-705-677; DTXSID80206205 |
C18H13NO4 |
307.3 |
c1(OC([H])([H])[H])c([H])c2c(c(N([H])C(=O)C2=O)c([H])c(c([H])c([H])c([H])c3[H])c34)c4c1OC([H])([H])[H] |
TCMBANKIN061676 |
aristolactam F I |
MCULE-4019596365; Piperolactam A; AC1MIW5I; Dibenz(cd,f)indol-4(5H)-one, 1-hydroxy-2-methoxy-; AKOS028108734; 15-HYDROXY-14-METHOXY-10-AZATETRACYCLO[7.6.1.0(2),?.0(1)(2),(1)?]HEXADECA-1(15),2,4,6,8,12(16),13-HEPTAEN-11-ONE; 15-HYDROXY-14-METHOXY-10-AZATETRACYCLO[7.6.1.0(2),?.0(1)(2),(1)?]HEXADECA-1(15),2(7),3,5,8,12(16),13-HEPTAEN-11-ONE; NP-013137; 112501-42-5; 1-Hydroxy-2-methoxydibenz(cd,f)indol-4(5H)-one; 1-Hydroxy-2-methoxydibenz[cd,f]indol-4(5H)-one, 9CI; 15-HYDROXY-14-METHOXY-10-AZATETRACYCLO[7.6.1.0(2),?.0(1)(2),(1)?]HEXADECA-1(16),2(7),3,5,8,12,14-HEPTAEN-11-ONE; 1-Hydroxy-2-methoxy-Dibenz[cd,f]indol-4(5H)-one; 15-hydroxy-14-methoxy-10-azatetracyclo[7.6.1.0;{2,7}.0;{12,16}]hexadeca-1(15),2,4,6,8,12(16),13-heptaen-11-one; Aristolactam F1; AristolactamFI; CHEMBL387864; Dibenz[cd,f]indol-4(5H)-one, 1-hydroxy-2-methoxy-; NCGC00385457-01_C16H11NO3_1-Hydroxy-2-methoxydibenzo[cd,f]indol-4(5H)-one; Aristolactam FI; 1-Hydroxy-2-methoxy-Dibenz(cd,f)indol-4(5H)-one; Dibenz[cd,f]indol-4(5H)-one,1-hydroxy-2-methoxy-; ZINC13484719; DTXSID90150083; W1104; 4CN-2034; MolPort-005-945-747; piperolactam a |
C16H11NO3 |
265.26 g/mol |
COC1=C(C2=C3C(=C1)C(=O)NC3=CC4=CC=CC=C42)O |